Kenvue’s stock hits fresh post-IPO lows as Tylenol parent company receives tepid reviews from analysts
May 30, 2023 at 15:27 PM EDT
Kenvue's stock hit new lows as Wall Street analysts start coverage of the Johnson & Johnson spinoff with halfhearted ratings.
